Iguana Healthcare Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Iguana Healthcare Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-400,000	Closed	-$4.96M	–	64
2016 Q3	$4.96M	Buy	400,000 +325,000	+433%	+$4.25M	0.88%	40
2016 Q2	$806K	Buy	+75,000	New	+$800K	0.33%	67
2015 Q2	–	Sell	-125,000	Closed	-$2.24M	–	73
2015 Q1	$2.25M	Buy	+125,000	New	+$1.96M	0.95%	38
2014 Q3	–	Sell	-25,000	Closed	-$375K	–	67
2014 Q2	$375K	Buy	+25,000	New	+$302K	0.17%	63

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Iguana Healthcare Management's AVDL Position: Q4 2016 in Review

Iguana Healthcare Management sold out of Avadel Pharmaceuticals (AVDL) in Q4 2016, closing a stake of 400,000 shares — an estimated $4.96M sold.

Iguana Healthcare Management first reported a position in AVDL in Q2 2014 and held it in 4 quarters. The position peaked at $4.96M in Q3 2016. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

Iguana Healthcare Management reported no remaining Avadel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Iguana Healthcare Management sold 400,000 Avadel Pharmaceuticals shares in Q4 2016, an estimated $4.96M.
Iguana Healthcare Management first reported a position in Avadel Pharmaceuticals in Q2 2014 and held it in 4 quarters.
Iguana Healthcare Management's Avadel Pharmaceuticals position peaked at $4.96M in Q3 2016.
76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on Iguana Healthcare Management's 13F filing for Q4 2016, filed 14 Feb 2017.